ArticleNeuro-oncology2022

IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.

Roberta Rudà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.